MCHRI Drug & Device Development Training Program



Clinical Fellows (MD or MD, PhD)*, Instructors, and Faculty who are able to complete the 4-week experience in four 1- week blocks, two 2-week blocks, or one 4-week block within a 4 month timeframe from a projected start date of Fall 2021 (specific date TBD). Applicants with an interest in pursuing career paths in translational medicine and medical product development will be preferred.

*The Stanford School of Medicine, Department of Graduate Medical Education (GME) Committee has approved the D3 Training Program as an elective to fulfill a portion of the fellow’s training.


To apply for the program, please submit the following as a compiled PDF document via email by Fall 2021 (Date TBD) to

  • 1-page personal statement
  • Applicant’s NIH Biosketch or CV
  • Letter of Nomination** from Department Chair, Division Chief or Training Program Director
    • **Letter must include commitment of salary support during the internship period
  • Simple budget and justification, not to exceed $1,500 in direct costs, with any necessary virtual learning expenditures (childcare costs are approved; computers and salary expenditures are prohibited)


Due to the virtual nature of the program, it is not anticipated that the awardee will require significant funding to complete the training program. However, we understand the uniqueness of the current environment and will consider the support of expenditures that will enable the learner to complete the training program successfully. Awarded funds will be provided via formal Notice of Award with the awardee’s financial representative responsible for reconciliation of proposed expenditures to award budget.

*Depending on COVID-19 regulations in the latter half of 2021, this training experience may have the capabilities to be hosted on location at an industry site. Please check back periodically for updates pertaining to the program.*

"D3 was a terrific program that fills a gap in fellowship education and provides a bridge to industry. Through the program, I joined a local biosciences company to work on developing a new therapeutic and diagnostic product. It was extremely valuable to be able to participate in these projects, especially as I gained experience moving through Phase 1 and Phase 2 trials."

Lauren Kushner, MD
Pediatric Infectious Diseases Fellow
Lucile Packard Children’s Hospital Stanford

For questions about applying, please contact Grant Wells.